Avalo Therapeutics Inc
(AVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,627 | 10,665 | 2,474 | 5,139 | 21,221 |
| Marketable Securities | 7,629 | N/A | N/A | N/A | N/A |
| Receivables | 5,242 | 6,085 | 7,115 | 133 | N/A |
| Inventories | 21 | 318 | 382 | N/A | N/A |
| Other current assets | 498 | 4,133 | 0 | 0 | 0 |
| TOTAL | $17,724 | $21,932 | $10,674 | $5,663 | $21,622 |
| Non-Current Assets | |||||
| PPE Net | 1,448 | 587 | 45 | 43 | 35 |
| Intangibles | 16,835 | 18,174 | 31,957 | 0 | 0 |
| Other Non-Current Assets | 102 | 29,558 | 131 | 63 | 0 |
| TOTAL | $18,385 | $48,319 | $32,133 | $106 | $35 |
| Total Assets | $36,109 | $70,251 | $42,807 | $5,769 | $21,658 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 2,354 | 3,208 |
| Accounts payable and accrued liabilities | 2,078 | 1,446 | 1,299 | 1,010 | 678 |
| Accrued Expenses | 5,640 | 14,329 | 7,531 | 948 | 1,886 |
| Other current liabilities | N/A | 860 | N/A | N/A | 78 |
| TOTAL | $12,161 | $26,217 | $11,089 | $4,312 | $5,850 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 2,354 |
| Other Non-Current Liabilities | 2,867 | 23,057 | 3,851 | 1,250 | 371 |
| TOTAL | $2,953 | $23,126 | $3,858 | $1,250 | $2,724 |
| Total Liabilities | $15,113 | $49,343 | $14,947 | $5,562 | $8,574 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20 | 15 | 11 | 4 | 3 |
| Common Shares | 44 | 41 | 31 | 9 | 9 |
| Retained earnings | -114,291 | -98,218 | -58,165 | -70,035 | -53,564 |
| Other shareholders' equity | 0 | 0 | 2,656 | 0 | 0 |
| TOTAL | $20,996 | $20,908 | $27,860 | $207 | $13,084 |
| Total Liabilities And Equity | $36,109 | $70,251 | $42,807 | $5,769 | $21,658 |